VNS Pipeline

Our platform technology has also shown promise in pre-clinical testing for numerous other neurological diseases using the device as a vagus nerve stimulator. MicroTransponder researchers are studying VNS for the treatment of tinnitus, stroke rehabilitation, anxiety, and several other neurological conditions. Our first VNS product will be the QuietStim™ System for treatment of tinnitus. The QuietStim™ System will require the patient to listen to a range of tones while receiving paired Vagus Nerve Stimulation. This method was able to permanently eliminate tinnitus in an animal model. We will be conducting clinical trials for this treatment in 2010. Vagus Nerve Stimulation has been proven safe and effective in humans for over 15 years as it has been used as a successful treatment for epilepsy in over 60,000 patients worldwide.